Tender Title: DGLP GEM RE 02
Tender Reference Number: GEM/2025/B/6133704
Issuing Authority: Department of Military Affairs, Ministry of Defence

Scope of Work and Objectives

The primary objective of this tender is to procure various pharmaceutical products, specifically a wide range of medication and supplies that caters to the medical needs of military personnel. The tender covers the supply of Acenocoumarol 1 mg and 4 mg tablets, the Acetazolamide 250 mg tablets, and a variety of other medications including injections and ointments suited for diverse treatment protocols. The total expected quantity for this procurement is 152,071 units across all listed products.

Eligibility Criteria

To participate in this tender, bidders must meet specific eligibility criteria:

• The bidder must be a legally registered entity in the pharmaceutical or healthcare sector.
• Proven experience in supplying similar products or services to governmental or military facilities will be an advantage.
• Compliance with all regulatory requirements governing pharmaceutical supplies.

Technical Requirements

Bidders must adhere to stringent technical specifications in accordance with industry standards, including:

• All medications supplied must be compliant with the relevant health and safety regulations.
• Products must be certified for quality standards, ensuring they meet ISO or GMP certifications.
• Appropriate documentation must be provided to substantiate the quality and efficacy of products being offered.

Financial Requirements

Bidders should be prepared to provide evidence of financial stability, including:

• Recent financial statements.
• No outstanding debts with governmental organizations.
• An Earnest Money Deposit (EMD) as specified in the tender documentation, ensuring serious intent to participate in the tender process.

Document Submission Details

All tender submissions must be duly completed and submitted electronically as per the guidelines outlined. Bidders are advised to ensure that all relevant documentation, including technical proposals and financial bids, are submitted before the stated deadline.

Special Provisions

This tender provides significant benefits for Micro, Small, and Medium Enterprises (MSEs) and startup companies, encouraging their participation by reducing competition barriers. Bidders qualifying as MSEs may experience extended payment terms and are encouraged to provide local content in their proposals to align with government policies.

Evaluation Process

The evaluation of submitted tenders will be conducted meticulously based on:

• Compliance with eligibility criteria.
• Adherence to technical specifications and requirements.
• Financial viability and cost-effectiveness of offers.
• Quality scrutiny through testing of samples if necessary.

Delivery Locations

The delivered goods are expected to reach designated military hospitals and healthcare facilities as provided in the tender documents. Bidders must clarify their logistics capabilities and provide reliable methods for timely delivery.

Contact Information

Although specific contact details were not available in the tender documentation, it’s recommended that bidders keep abreast of updates through the official tender portal and scheduled communications.

This tender represents a significant opportunity for pharmaceutical suppliers to support the health and welfare of military personnel while adhering to rigorous quality and governance standards.